US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist
  • 28.270
  • +0.500+1.80%
Close May 8 16:00 ET
  • 28.260
  • -0.010-0.04%
Post 19:59 ET
160.08BMarket Cap-565400P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pfizer Earnings Date

Currency: USD

Period

Q1 2024 Earnings

May 1, 2024

Revenue(YoY)

14.88B

-19.51%
EPS(YoY)

0.55

-43.30%
Analyst Rating

Buy

May 8, 2024

Pfizer Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 14.806B--
--2024/Q2-- / 13.031B--
May 1, 20242024/Q114.879B / 13.923B--
Jan 30, 20242023/Q414.249B / 14.396B--
Oct 31, 20232023/Q313.232B / 13.429B--
Aug 1, 20232023/Q212.734B / 13.398B--
May 2, 20232023/Q118.282B / 16.488B--
Jan 31, 20232022/Q424.290B / 24.393B--
Nov 1, 20222022/Q322.638B / 21.091B--
Jul 28, 20222022/Q227.742B / 26.199B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 14.806B--
--2024/Q2-- / 13.031B--
May 1, 20242024/Q114.879B / 13.923B--
Jan 30, 20242023/Q414.249B / 14.396B--
Oct 31, 20232023/Q313.232B / 13.429B--
Aug 1, 20232023/Q212.734B / 13.398B--
May 2, 20232023/Q118.282B / 16.488B--
Jan 31, 20232022/Q424.290B / 24.393B--
Nov 1, 20222022/Q322.638B / 21.091B--
Jul 28, 20222022/Q227.742B / 26.199B--

Unlock Free Earnings Estimates

Pfizer Earnings Reports

  • Pfizer | 10-Q: Quarterly report

    15:59 ET

  • Pfizer | 10-K: Annual report

    Feb 22 13:22 ET

  • Pfizer: Q3 2023 Earnings Report

    Nov 8, 2023 16:00 ET

  • Pfizer | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 8, 2024

    Buy

    • Buy

      47.37%

    • Hold

      52.63%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+0.68%
    Cancer Research
    Cancer Research
    Intraday+0.02%